MAP2K7 and malignant colon neoplasm: In addition, it also shows that the anticancer efficacy of ATP-competitive inhibitors of mTOR is potentiated by the simultaneous pharmacological blockade of the MEK/MAPK signaling pathway in colon cancer cells.